MAPT and early-onset autosomal dominant Alzheimer disease: Critically, we did not examine direct associations between SF-BrainOK scores and pathophysiological indicators of Alzheimer’s disease pathology, such as amyloid-beta, tau, or neurodegeneration assessed via PET or MRI [56,57].